Dr. Reddys Labs (RDY) Posts Improved Q2 EPS of 50c/Share

Dr. Reddys Labs (NYSE: RDY) reported Q2 EPS of $0.50, versus $0.30 reported last year. Revenue for the quarter came in at $544 million, versus $429 million reported last year.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• RUM Group to raise Northern Data stake to ~98% via share purchase
• Copart (CPRT) Misses Q4 EPS by 4c